Abu Dhabi to test new IVF technology in 2027
Abu Dhabi: A new fertility research project in Abu Dhabi will investigate whether an innovative laboratory system can help scientists better understand embryo development during in-vitro fertilisation (IVF), potentially paving the way for improvements in fertility treatment. The clinical investigation, expected to enrol its first participant in 2027, follows a partnership between ART Fertility…
Abu Dhabi is set to trial cutting-edge fertility technology in 2027, with the aim of enhancing understanding of embryo development during in-vitro fertilisation (IVF). The clinical trial, spearheaded by ART Fertility Clinics and its partner dawn-bio GmbH, follows a Memorandum of Understanding (MoU) signed at the Abu Dhabi Future Health Summit 2026.
The Offspring™ IVF culture system, developed by dawn-bio, will be evaluated to determine if changes in laboratory conditions could influence early embryo development. Despite the potential benefits, no improvements in pregnancy or birth outcomes have been established through this proposed research. The first participant is expected to join the study in 2027, pending approval from the Department of Health - Abu Dhabi's Ethics Committee and adherence to international medical-device research standards.
Patient safety and informed consent are top priorities, with all research activities subject to strict data protection laws. This partnership reflects Abu Dhabi's commitment to becoming a global hub for reproductive medicine, fostering collaboration between healthcare providers, researchers, and biotechnology companies to advance fertility care.
Written by urgent.news from Gulf News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
